Drug intelligence / Profile preview

xuanfei jiedu decoction

Development stage: Unknown
Lead developer: Shanghai Municipal Hospital of Traditional Chinese Medicine
Administration: Oral

Overview

Xuanfei Jiedu Decoction is a Traditional Chinese Medicine (TCM) herbal formula developed for the treatment of respiratory viral infections, specifically COVID-19. Developed by the Shanghai Hospital of Traditional Chinese Medicine, it is designed to ventilate the lungs (Xuanfei) and clear toxins (Jiedu), addressing symptoms such as cough, fever, and lung congestion. In clinical studies, it has been evaluated for its efficacy in children with asymptomatic or mild COVID-19 variant infections, often compared against standard care or interferon nebulization. The formula typically consists of a combination of botanical extracts known for their anti-inflammatory and antiviral properties in TCM practice.

Other names: Xuanfei Jiedu FormulaXuanfei Jiedu Fang宣肺解毒方

Beyond the preview

Go deeper on xuanfei jiedu decoction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on xuanfei jiedu decoction.

Explore the full profile